öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÑî¾²Óñ
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º388

ËùÊôԺУ£ºÉòÑôÒ©¿Æ´óѧ
ËùÊôԺϵ£ºÉúÃü¿ÆѧÓëÉúÎïÖÆҩѧԺ
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼/²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©Àíѧ¡¢ÁÙ´²Ò©Ñ§¡¢ÖÐÒ©Ò©Àíѧ¡¢Ò©Ñ§(ÁÙ´²Ò©Ñ§Ñо¿·½Ïò)¡¢Ò©Ñ§(Ò©ÀíѧÑо¿·½Ïò)¡¢ÖÐҩѧ(ÖÐÒ©Ò©ÀíѧÑо¿·½Ïò)
Ñо¿ÁìÓò£º Ñо¿·½ÏòÒ»£ºÉñ¾­ÍËÐÐÐÔ¼²²¡¡¢¾«ÉñÕÏ°­µÈ¼²²¡µÄ·¢²¡»úÖÆÓëÒ©ÎïÑо¿£»Ñо¿·½Ïò¶þ£º³Éñ«ÐÔÒ©ÎﾫÉñ... [Õ¹¿ª]


Ñо¿ÁìÓò£º Ñо¿·½ÏòÒ»£ºÉñ¾­ÍËÐÐÐÔ¼²²¡¡¢¾«ÉñÕÏ°­µÈ¼²²¡µÄ·¢²¡»úÖÆÓëÒ©ÎïÑо¿£»Ñо¿·½Ïò¶þ£º³Éñ«ÐÔÒ©ÎﾫÉñÒÀÀµÐÔ²úÉú»úÖÆÓëÒ©ÎïÑо¿£»Ñо¿·½ÏòÈý£ºÖÐÊàÉñ¾­ÏµÍ³¼²²¡ÓëÖ×ÁöµÄѯ֤ҩѧÑо¿ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºyangjingyu2006@gmail.com
ͨѶµØÖ·£ºÉòÑôÊÐÉòºÓÇøÎÄ»¯Â·103ºÅ


¸öÈ˼òÊö :
Ñî¾²Óñ£¬Å®£¬²©Ê¿£¬½ÌÊÚ¡£1993Äê±ÏÒµÓÚÉòÑôÒ©¿Æ´óѧ£¬1996Äê»ñµÃÉòÑôÒ©¿Æ´óѧ˶ʿѧ룬2000Äê»ñµÃÉòÑôÒ©¿Æ´óѧ²©Ê¿Ñ§Î»£¬2002Äê±»ÆÀΪ¸±½ÌÊÚ¡¢Ë¶Ê¿Éúµ¼Ê¦£¬2006Äê±»ÆÀΪ½ÌÊÚ¡¢²©Ê¿Éúµ¼Ê¦¡£ÔøÓÚ1998-2000Ä기ÈÕ±¾¶«¾©´óѧÁôѧ¡£Ä¿Ç°ÊÇÒ©Àíѧ·Ö¿ÆÖ÷ϯ¡¢ÁÙ´²Ò©Ñ§öλÔÓéÀֵǼÈë¿ÚÏÂÔظºÔðÈË¡¢ÉúÃü¿ÆѧÓëÉúÎïÖÆҩѧԺԺ³¤¡£ËùÔÚ¿ÎÌâ×éΪÊǹú¼Ò¡°Ê®Ò»Î塱ÖØ´óÐÂÒ©´´ÖÆ×ÛºÏƽ̨ÁÉÄþÊ¡ÐÂÒ©´´ÖÆ×ÛºÏƽ̨µÄÖØÒª×é³É²¿·Ö£¬Á¥ÊôÓÚ¹ú¼ÒÖÐÒ½Ò©¾ÖÖصãÑо¿ÊÒ¡¢ÁÉÄþÊ¡ÐÂҩɸѡʵÑéÊÒ¡¢ÁÉÄþÊ¡ÐÂҩҩЧÆÀ¼ÛÖصãʵÑéÊÒ¡£×÷Ϊ¸ºÔðÈËÏȺó³Ðµ£Á˹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¨3Ï¡¢¿Æ¼¼²¿¡°Ê®Ò»Î塱¡¢¡°Ê®¶þÎ塱ÖØ´óÐÂÒ©´´ÖÆÏîÄ¿×ÓÏîÄ¿µÈÏîÄ¿¡£ÒÑÔÚNatureNanotechnololgy, Pharmacology Therapeutics, Journal of Neuroscience, Cancer Letter,Free Radical Biology Medicine, OncotargetµÈÆÚ¿¯·¢±íÎÄÕ°ÙÓàƪ¡£

¿ÆÑй¤×÷ :
½üÄêÀ´·¢±í´ú±íÐÔÂÛÎÄ£º1.Xue X1, Yang JY1, He Y1,Wang LR, Liu P, Yu LS, Bi GH, Zhu MM, Liu YY, Xiang RW, Yang XT, Fan XY, WangXM, Qi J, Zhan HJ, Wei T, Cui W, Ge GL, Xi ZX*, Wu CF*, Liang XJ*. Aggregatedsingle-walled carbon nanotubes attenuate the behavioural and neurochemicaleffects of methamphetamine in mice.Nature Nanotech, 2016,11(7):613-20.(IF=35.267)(News and ViewsNanomedicine: Going small to beat the high by Dr. Eric C. Peterson & LauraE. Ewing2.Yang JY*, Xue X, Tian H, Wang XX, Dong YX,Wang F, Zhao YN, Cui W, Wu CF*. Role of microglia in ethanol-inducedneurodegenerative disease: Pathological and behavioral dysfunction at differentdevelopmental stages. Pharmacol Ther. 2014,144(3):321-372. (IF=7.745)3.Wang LH, Chen GL, Chen K, Ren Y, Li HH, Jiang XR, Jia L, Fu SY, Li Y, Liu XW, Wang S, Yang JY*, WuCF*. Dualtargeting of retinoid X receptor and histone deacetylase with DW22 as a novelantitumor approach. Oncotarget,20156(12): 9740-9755. (IF=6.359)4.Zhu XN, Liu XD, Zhuang HY, Henkemeyer M, Yang JY*,Xu NJ*. Amygdala EphB2 Signaling Regulates Glutamatergic Neuron Maturation andInnate Fear.J Neurosci. 2016, 36(39): 10151¨C10162. (IF=5.98)5.Wang FY, Wang LH, ZhaoYF, Li Y,Ping GF, Xiao S, Chen K, Zhu WF, Gong P*, Yang JY*, Wu CF*. A novel small-molecule activator of procaspase-3induces apoptosis in cancer cells and reduces tumor growth in human breast,liver and gallbladder cancer xenografts. Mol Oncol. 2014, 8(8):1640-52. ( IF=5.935)6.Tian H, Ye XX,Hou XJ, Yang XW, Yang JY*, Wu CF*.SVCT2, a potential therapeutic target, protects against oxidative stress duringethanol-induced neurotoxicity via JNK/p38 MAPKs, NF-¦ÊB and miRNA125a-5p. Free Radical BioMed. 2016, 96:362-373. (IF=5.7367.Li Y , Fu SY, Wang LH, Wang FY,Wang NN, Cao Q, Wang Y T, Yang JY*, Wu CF* . Copper improves theanti-angiogenic activity of Disulfiram through the EGFR/Src/VEGF pathway ingliomas. Cancer Lett .**: 86-96. (IF=5.621)8.Liu P, Wu CF, Song W,Yu LS, Yang XF, Xiang RW, Wang F, YangJY*. Uridine decreases morphine-induced behavioral sensitization bydecreasing dorsal striatal dopamine release possibly via agonistic effects AtGABAA receptors. Eur Neuropsychopharmacol. 2014, 24(9):1557-66. (IF=5.395)9.Liu XW, Wang LH, Cui W,Yuan XZ, Lin LL, Cao Q, Wang NN, Li Y, Guo W, Zhang X, Wu CF*, Yang JY*. Targeting ALDH1A1 byDisulfiram/copper complex inhibits non-small cell lung cancer recurrence drivenby ALDH-positive cancer stem cells. Oncotarget, Epub 2016 Aug.(IF=5.008)10.WangXX, Wang CM, Wang JM, Zhao SQ, Zhang K, Zhang W, Wu CF*, Yang JY*.Pseudoginsesenoside-F11(PF11) exerts anti-neuroinflammatory effects onLPS-activated microglia cells by inhibiting TLR4-mediated TAK1/IKK/NF-¦ÊB, MAPKsand Akt signaling pathways. Neuropharmacology. 2014,79:642-656.(IF=4.819)